Showing results (251-260 of 7,001) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancerGregory A Masters, Elizabeth A Hahn, Daniel H Shevrin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Endobronchial carcinoid tumor combined with pulmonary non-tuberculous mycobacterial infection: report of two casesYoshihiro Nakamura, Yoshinori Okada, Chiaki Endo, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Lung cancer screening by spiral CT. What is the optimal target population for screening trials?Rob J van Klaveren, Harry J de Koning, James Mulshine, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Clinical significance of P16INK4A and retinoblastoma proteins in non-small-cell lung carcinomaHale Akin, Dilek Yilmazbayhan, Zeki Kiliçaslan, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic valuesChikako Takezawa, Hiroki Takahashi, Takuya Fujishima, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancerKoji Takeda, Nobuhide Takifuji, Hisao Uejima, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancerJosé Miguel Sánchez, Carme Balañá, Albert Font, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissueMihi Yang, Brian F Coles, Robert Delongchamp, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancerSumeet Bhatia, Nasser Hanna, Rafat Ansari, et al.
Pageof 701